C4 Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| LYNX1 CAPITAL MANAGEMENT LP | 11/14/2024 | 6.88 M | $39.22 B | 0.00% | 9.88% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 6.60 M | $37.64 M | 62.98% | 9.48% |
| WASATCH ADVISORS LP | 11/14/2024 | 5.68 M | $32.36 M | 17.13% | 8.15% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.89 M | $27.88 M | 100.00% | 7.02% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 4.88 M | $27.80 M | 0.00% | 7.01% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 4.38 M | $24.95 M | 189.34% | 6.29% |
| COMMODORE CAPITAL LP | 11/14/2024 | 3.41 M | $19.44 M | 0.00% | 4.90% |
| VANGUARD GROUP INC | 11/13/2024 | 3.37 M | $19.21 M | -5.23% | 4.84% |
| STATE STREET CORP | 11/14/2024 | 2.81 M | $16.00 M | -6.28% | 4.03% |
| MORGAN STANLEY | 11/14/2024 | 2.33 M | $13.26 M | 104.42% | 3.34% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 2.04 M | $11.61 M | 15.14% | 2.92% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.37 M | $7.81 M | 0.55% | 1.97% |
| ARROWMARK COLORADO HOLDINGS LLC | 11/14/2024 | 1.32 M | $7.52 M | 6.04% | 1.90% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 1.20 M | $6.85 M | 331.42% | 1.73% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.15 M | $6.54 M | -20.44% | 1.65% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 11/14/2024 | 1.11 M | $6.34 M | 0.00% | 1.60% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 1.07 M | $6.07 M | -23.45% | 1.53% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 828,490 | $4.72 M | -36.65% | 1.19% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 700,000 | $3.99 M | 250.00% | 1.01% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 578,885 | $3.30 M | -6.50% | 0.83% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 520,000 | $2.96 M | 100.00% | 0.75% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 505,852 | $2.88 M | -31.44% | 0.73% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 482,929 | $2.75 M | -1.23% | 0.69% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 392,004 | $2.24 M | 529.15% | 0.56% |
| UBS GROUP AG | 11/14/2024 | 334,081 | $1.90 M | -17.33% | 0.48% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 286,041 | $1.63 M | 24.72% | 0.41% |
| TREXQUANT INVESTMENT LP | 11/12/2024 | 266,159 | $1.52 M | 124.66% | 0.38% |
| BARCLAYS PLC | 11/19/2024 | 243,457 | $1.39 M | 38.40% | 0.35% |
| MARSHALL WACE, LLP | 11/14/2024 | 225,416 | $1.28 M | 100.00% | 0.32% |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 10/22/2024 | 192,364 | $1.10 M | 34.68% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 187,600 | $1.07 M | -28.10% | 0.27% |
| FMR LLC | 11/13/2024 | 185,941 | $1.06 M | 686.99% | 0.27% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 180,853 | $1.03 M | -58.04% | 0.26% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 150,000 | $855,000 | 100.00% | 0.22% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 150,000 | $855,000 | 100.00% | 0.22% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 147,874 | $842,882 | 158.90% | 0.21% |
| RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 143,855 | $819,974 | -22.55% | 0.21% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 143,293 | $816,773 | -24.88% | 0.21% |
| JUMP FINANCIAL, LLC | 11/14/2024 | 134,636 | $767,425 | -39.68% | 0.19% |
| MARINER, LLC | 11/13/2024 | 130,411 | $743,343 | 1.98% | 0.19% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 122,373 | $697,526 | 11.17% | 0.18% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 118,892 | $677,684 | -66.62% | 0.17% |
| M&T BANK CORP | 11/19/2024 | 113,907 | $649,407 | 19.35% | 0.16% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 103,026 | $587,250 | -81.63% | 0.15% |
| RHUMBLINE ADVISERS | 11/12/2024 | 95,649 | $545,195 | 5.55% | 0.14% |
| CITADEL ADVISORS LLC | 11/14/2024 | 85,100 | $485,070 | 74.03% | 0.12% |
| VIENNA POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. VIENNA INSURANCE GROUP | 11/07/2024 | 85,000 | $484,500 | 0.00% | 0.12% |
| XTX TOPCO LTD | 11/14/2024 | 84,951 | $484,221 | 100.00% | 0.12% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 80,499 | $458,000 | 91.20% | 0.12% |
| ARETE WEALTH ADVISORS, LLC | 11/18/2024 | 73,350 | $418,000 | -34.10% | 0.11% |
C4 Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 141 institutional investors and hedge funds held shares of C4 Therapeutics, Inc.. The most heavily invested institutionals were:
GAMMA Investing LLC: 0
SG Americas Securities, LLC: 0
NISA INVESTMENT ADVISORS, LLC: 0
Lynx1 Capital Management LP: 6.88 M
Soleus Capital Management, L.P.: 6.6 M
WASATCH ADVISORS LP: 5.68 M
91.98% of C4 Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 68.70 M shares in the last 24 months. This purchase volume represents approximately $252.11 M in transactions.